Pneumonia Therapeutics Market is Excellent CAGR 8.1%, Research Report, Growth, Share, Trends, Opportunities, & Forecast 2030

Pneumonia Therapeutics Market research report explores the major parameters for Healthcare industry namely market analysis, market definition, market segmentation, key developments in the market, competitive analysis, and research methodology. With the market statistics included in this market document, getting a global perspective for the international business has become quite easy. The report normally includes major manufacturers, suppliers, distributors, traders, customers, investors, major types, and major applications. The universal Pneumonia Therapeutics Market report also presents the company profile, product specifications, capacity, production value, and 2022-2029 market shares for each company under Healthcare industry.

Data Bridge Market Research analyses a growth rate in the pneumonia therapeutics market in the forecast period 2023-2030. The expected CAGR of hypophosphatemia treatment market is around 8.1% in the mentioned forecast period. The market was valued at USD 2.15 billion in 2022, and it would grow upto USD 4 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-pneumonia-therapeutics-market

Pneumonia is an inflammatory medical condition that affects the air sacs and alveoli in the lungs. Pathogens such as bacteria, virus and fungi are causing the pneumococcal infection through inhalation of air borne droplets from sneeze or cough. It can also be caused by contact with objects and surfaces contaminated with pneumonia causing bacteria and virus. According to WHO, the annual incidence is around 150.7 million cases, of which 7% to 13% require intensive treatment.

Global Pneumonia Therapeutics Market Dynamics

Drivers

Rising Demand of Antiviral Drugs

Viral pneumonia spreads through fluid present in the air droplets after an individual coughs or sneezes. These fluids enter into the body through mouth or nose. Numerous treatment options such as  oseltamivir and acyclovir among others are used to treat the antiviral infection. Likewise, these drugs help reduce the severity of flu virus spreading into the body, further enhancing the market progression. Thus, the more and more consumption of antiviral drugs acts as a major driver of growth in the global pneumonia therapeutics market.

Growing number of hospital-acquired pneumonia infections

Hospital-acquired pneumonia is a lung infection which occurs during hospital stays. Majority of patients with hospital-acquired pneumonia develop severe complications that include renal failure, respiratory failure and empyema because of severe and weak health conditions. Thus, increasing occurrences of hospital-acquired pneumonia will increase the demand for pneumonia therapeutics drugs.

Key players operating in the pneumonia therapeutics market include:

AstraZeneca (U.K.)
Lilly (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Novartis AG (Switzerland)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
Lupin (India)
Merck & Co., Inc. (U.S.)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Hikma Pharmaceuticals PLC (U.K.)
Cipla Inc. (India)
Lupin (India) 

 Browse More Reports

https://dbmrmarkett.blogspot.com/2023/07/medical-microcontrollers-market-growing.html

https://dbmrmarkett.blogspot.com/2023/07/healthcare-information-software-market.html

https://dbmrmarkett.blogspot.com/2023/07/europe-fiber-optic-gyroscope-market.html

https://dbmrmarkett.blogspot.com/2023/07/north-america-laboratory-information.html

About Us

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. "Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve."

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com

This release was published on openPR.